脑部放疗,上午比下午敏感许多!7 J6 P7 w1 K5 I! p6 ?( W' O8 o
$ h* f/ b/ V5 [1 u; M3 s2 ^# e# E
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
6 P) b: e V0 rGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?3 t, C2 F5 o5 q+ j& p, ]
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.1 \, |. f9 M% S
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
( E( z. A# I0 Y, C7 ^# @% Y* R$ u/ Y
" Y2 { h7 k1 E; ~4 p& SAbstract j/ i$ \: b5 t% x/ T0 e5 e
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.9 b4 B1 Q; N( w/ c a0 |/ Q
" p1 Z4 D2 ^/ T; r
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
# f7 p2 ?2 W8 T+ P" Q6 }" M: l6 K8 G7 H/ E+ O5 s f
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
' }% L7 h8 M+ F; X; p! C
. H" B4 }* ]/ [# SCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
& D0 o1 {* ] C& T/ j$ Y' Z5 S, Z- A* j! `6 v# l, a, K5 Y, N
|